In SH-SY5Y human neuroblastoma cells, insulin-like growth factor (IGF)-l mediates membrane ruffling and growth cone extension. We have previously shown that IGF-l activates the tyrosine phosphorylation of focal adhesion kinase (FAK) and extracellular signal-regulated protein kinase (ERK) 2. In the current study, we examined which signaling pathway underlies IGF-I-mediated FAK phosphorylation and cytoskeletal changes and determined if an intact cytoskeleton was required for IGF-I signaling. Treatment of SH-SY5Y cells with cytochalasin D disrupted the actin cytoskeleton and prevented any morphological changes induced by IGF-I. Inhibitors of phosphatidylinositol 3-kinase (P1 3-K) blocked IGF-l-mediated changes in the actin cytoskeleton as measured by membrane ruffling. In contrast, P098059, a selective inhibitor of ERK kinase, had no effect on IGF-l-induced membrane ruffling. In parallel with effects on the actin cytoskeleton, cytochalasin D and P1 3-K inhibitors blocked IGF-l-induced FAK tyrosine phosphorylation, whereas PD98059 had no effect. It is interesting that cytochalasin D did not block IGF-l-induced ERK2 tyrosine phosphorylation. Therefore, it is likely that FAK and ERK2 tyrosine phosphorylations are regulated by separate pathways during IGF-l signaling. Our study suggests that integrity as well as dynamic motility of the actin cytoskeleton mediated by P1 3-K is required for IGF-I-induced FAK tyrosirle phosphorylation, but not for ERK2 activation. Key Words: Insulin-like growth factor 1-Actin cytoskeleton-Focal adhesion kinase-Extracellular signal-regulated protein kinase-Phosphatidylinositol 3-kinase. J. Neurochem. 71, 1333Neurochem. 71, -1336Neurochem. 71, (1998.
Insulin-like growth factor (IGF)-I is a polypeptide that plays an essential role in embryonic and early postnatal development (Zackenfels et al., 1995) . In the nervous system, IGF-I is important for cytoskeletal organization and extension of growth cones. These changes in neuronal architecture require IGF-I-mediated redistribution of the actin cytoskeleton (Kadowaki et al., 1986; .
We are interested in the downstream signaling pathways activated by IGF-I during nervous system growth. We have reported that IGF-I binds to the type I IGF receptor and activates the mitogen-activated protein (MAP) kinase and phosphatidylinositol 3-kinase (P1 3-K) pathways Leventhal and Feldman, 1997; Leventhal et al., 1997; Cheng and Feldman, 1998) . Our work suggests that the physiological effects of each pathway are separable. For example, IGF-I activation of extracellular signal-regulated protein kinase (ERK) 2, the most studied member of the MAP kinase family, results in neuronal differentiation , whereas IGF-I blocks neuronal apoptosis via P1 3-K signaling (Singleton et al., 1996) . We do not know the relationship between these two pathways and the ability of IGF-I to reorganize the actin cytoskeleton. Furthermore, it is not known if cytoskeletal organization is a prerequisite for one or more aspects of IGF-I-mediated signaling.
To answer these questions, we initially investigated one downstream target of P1 3-K, focal adhesion kinase (FAK). FAK is a cytoplasmic tyrosine kinase (Ilic et al., 1997; Zachary, 1997 ) instrumental in growth factor-mediated changes in cytoskeletal organization (reviewed by Carpenter and Cantley, 1996) . IGF-I and insulin can either phosphorylate or dephosphorylate FAK, depending on the cell type and the adhesion status (Pillay et al., 1995; Leventhal et al., 1997; Baron et al., 1998) . We have found that IGF-I stimulates the tyrosine phosphorylation of FAK in neurons as growth cones advance over the substrate ).
In the current study, we examined which signaling pathway underlies IGF-I-mediated FAK phosphorylation and cytoskeletal changes and determined if an intact cytoskeleton was required for IGF-I signaling. In our experiments, we used SH-SY5Y human neuroblastoma cells, a well-studied in vitro model of neuronal growth and differentiation (Feldman and Randolph, 1991; Lavenius et al., 1994; Leventhal et al., 1995) . We report that IGF-I-mediated FAK tyrosine phosphorylation and changes in neuronal morphology require P1 3-K signaling. Wealso found that disruption of the actin cytoskeleton blocks IGF-I activation of FAK but has no effect on IGF-I activation of MAP kinase pathways. These results are discussed in terms of a general model of growth factor-mediated changes in neuronal architecture. 
MATERIALS AND METHODS

Materials
Anti-phosphotyrosine antibodies were purchased as follows: PY2O from Transduction Laboratories (Lexington, KY, U.S.A.) and 4G10 from Upstate Biochemicals (Lake Placid, NY, U.S.A.). Anti-FAK and anti-ERK2 polyclonal antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.). LY294002 and wortmannin were purchased from Biomol ( 
Cell culture
SH-SY5Y human neuroblastoma cells were grown in Dulbecco's modified Eagle's medium containing 10% calf serum and maintained at 37°C in a humidified atmosphere with 10% CO 2. For immunocytochemistry experiments, cells were grown on glass coverslips. At 18-24 h before experiments, medium was replaced with Dulbecco's modified Eagle's medium without serum.
Immunoprecipitation, immunoblotting, and immunocytochemistry
Immunoprecipitation and immunoblotting were performed as described previously . All experiments were repeated at least twice, and typical representative results are shown in the figures. Immunocytochemistry was performed as described previously . SH-SY5Y cells grown on glass coverslips were fixed in 4% paraformaldehyde and permeabilized in 0.15% Triton X-lOO plus 1% bovine serum albumin in phosphate-buffered saline, pH 7.2. Actin filaments were stained for 15 mm with 2 units/ml rhodaminephalloidin (Molecular Probes, Eugene, OR, U.S.A.).
RESULTS
We first examined the organization of the actin filaments in SH-SY5Y cells by staining with rhodamine-labeled phalloidin. In control cells, we could detect a distinct organization of actin cytoskeleton, including stress fibers and fibpodia (Fig. 1A) . Actin filaments were especially concentrated at the periphery of the cells. In agreement with our previous results , treatment of IGF-I resulted in the extension of growth cones. When these cells were stained with rhodamine-phalloidin, there was a dense staining of actin filaments at the leading membrane edges, representing membrane ruffling (Fig. 1B) . Cytochalasin D treatment produced a gross disruption of the actin cytoskeleton with rounding up of the cells (Fig. 1C) . Actin filaments were redistributed into discrete round patches scattered randomly over the cells. IGF-I treatment had no effect on these changes. Treatment with two P1 3-K inhibitors alone, LY294002 and wortmannin, had little effect on the actin cytoskeleton; we did not observe differences in actin stress fibers of cells treated with wortmannin versus LY294002 (data not shown). Stress fibers and filopodia were also maintained. However, these compounds prevented growth cone extension and membrane ruffling after IGF-I treatment ( Fig.  1D and B) . In contrast, PD98059, an inhibitor of MAP kinase kinase, did not block IGF-I-inducedgrowth cone exten- sion and membrane ruffling (Fig. IF) at doses up to 100 ,uM (data not shown).
Next we examined the changes in tyrosine phosphorylation of FAK and ERK2. In agreement with our previous reports , IGF-1 treatment resulted in increased tyrosine phosphorylation of FAK and ERK2 (Fig. 2) . Treatment of cytochalasin D completely abolished IGF-I-induced FAK tyrosine phosphorylation ( Fig. 2A) . In contrast, cytochalasin D had no effect on ERK2 tyrosine phosphorylation (Fig. 2B) . Recent reports show that P1 3-K activity is required for platelet-derived growth factor-induced FAK tyrosine phosphorylation (Rankin et al., 1996; Saito et al., 1996) . In agreement with these reports, IGF-I-induced FAK tyrosine phosphorylation was blocked by treatment of the cells with the P1 3-K inhibitors LY294002 and wortmannin (Fig. 2C) . In contrast, PD98059, which inhibits IGF-I-induced ERK2 activity , had no effect on FAK tyrosine phosphorylation (Fig. 2D) .
DISCUSSION
In the current study, we investigated which downstream signaling pathway mediates the ability ofIGF-I to reorganize the actin cytoske!eton and produce membrane ruffling in neurons. We found that two structurally unrelated P1 3-K inhibitors, LY294002 and wortmannin, blocked IGF-I-mediated membrane ruffling. In contrast, PD98059, which can effectively block IGF-I activation of ERK2 , had no effect on the ability of IGF-I to produce ruffled membranes. These data indicate that IGF-I-mediated changes in actin reorganization and the neuronal cytoskeleton are mediated via P1 3-K signaling. Our results agree with reports in nonneuronal cells. In fibroblasts, membrane ruffling is stimulated by several growth factors, including IGF-I (Kotani et al., 1994; Wennström et al., 1994) . In nonneuronal cells, activation of P1 3-K is necessary for membrane ruffling by acting as an upstream regulator of the small GTPase protein, Rac (Kotani et al., 1994; Nishiyama et al., 1994; Wennstrdm et al., 1994; Hawkins et al., 1995; Parker, 1995) . We are currently investigating the role of P1 3-K activation of Rac in IGF-I-mediated changes in neuronal architecture (Kim et al., 1996) .
In this report, we also show that tyrosine phosphorylation of FAK and ERK2 is differentially regulated by cytochalasin D. IGF-I activation of FAK is blocked by cytochalasin D, whereas the same treatment has no effect on IGF-I-mediated ERK2 activation. FAK can be activated by integrin clustering, adhesion to the extracellular matrix (ECM), and growth factor stimulation (Ilic et a!., 1997; Zachary, 1997) . We have also reported that binding of SH-SY5Y cells with laminm can induce FAK tyrosine phosphorylation (Leventhal and Feldman, 1996b; Leventhal et al., 1997) . Our current study suggests that integrity of actin filaments is critical for FAK, but not ERK2, activation in neurons and that FAK and ERK2 tyrosine phosphorylations are regulated by separate pathways during IGF-I stimulation. These data imply that first an external stimulus, provided by a growth factor, integrin-ECM binding, or both, reorganizes the actin cytoskeleton. Cytoskeletal rearrangement activates proteins like FAK, which form focal adhesions between the cell and ECM . In contrast, ERK2 is directly activated by IGF-I and does not require changes in neuronal architecture for IGF-I-mediated activity.
Our results point out interesting differences between nonneuronal and neuronal cells. In fibroblasts, IGF-I deactivates FAK as cells attach and organize their cytoskeleton (Baron et a!., 1998) . In contrast, we find that IGF-I activates FAK as neurons attach and organize their cytoskeleton. Our data emphasize the importance of an intact cytoskeleton for growth factor-mediated FAK activation in neurons. Unlike fibroblasts, neurons must form growth cones, which protrude into the substratum and form the pathway for neurites. Our results suggest that activation of FAK promotes the formation of focal adhesions in the organized neuronal actin cytoskeleton, permitting attachment and extension of growth cones required for neurite outgrowth. Thus, in neurons, FAK provides a unique point of convergence among organization of the actin cytoskeleton, growth factor signaling, and formation of focal adhesions.
The current study does not address the question of whether or not integrin-ligand binding activates MAP kinases in SH-SY5Y cells. However, our previous studies suggest integrin-ECM binding does not activate this pathway (Leventhal and Feldman, 1996a,b) . In the current study, we demonstrate that cytoskeletal disruption has no effect on growth factormediated MAP kinase activation. These new results again emphasize the differences between nonneuronal cells and neurons. In contrast to our data in neurons, reports in fibroblasts suggest integrin binding with ECM activates MAP kinases (Chen et al., 1994; Morino et al., 1995) and overexpression of FAK enhances fibronectin-stimulatedERK2 activation (Schlaepfer and Hunter, 1997) . Recently, however two studies suggest the existence of independent integrin signaling pathways in fibroblasts, one of which can activate FAK and one of which affects MAP kinase (Seufferlein et al., 1996; Lin et al., 1997) . These ideas agree more with our own observations that MAP kinase and FAK tyrosine phosphorylations are regulated by separate pathways.
In the current study, the PT 3-K inhibitor LY294002 blocked IGF-I-mediated membrane ruffling. We also found that LY294002 and wortmannin block IGF-I-induced FAK tyrosine phosphorylation. In contrast, PD98059 had no effect. These results are in agreement with recent reports where FAK associates with P1 3-K and P1 3-K activity is required for platelet-derived growth factor-induced FAK tyrosine phosphorylation (Chen and Guan, 1994a,b; Rankin et al., 1996; Saito et a!., 1996) . Collectively, our data and those of others (Chen and Guan, 1994a,b; Rankin et al., 1996; Saito et a!., 1996) suggest that not only integrity but also dynamic motility of the actin cytoskeleton is required for IGF-I-induced FAK tyrosine phosphorylation.
Our findings in neurons are also important in the context of recent reports, including our own (Singleton et al., 1996) , that growth factor protection against neuronal apoptosis is mediated via P1 3-K pathways. Accumulating data show a strong association among apoptosis, cellular adhesion, and the cytoskeleton. FAK is also now known to be a substrate for caspase-3, a protease that serves as a cellular death effector (Widmann et a!., 1998) . Our results in neurons that both IGF-I-mediated FAK activation and IGF-I protection against apoptosis require PT 3-K activation suggest an interesting link between FAK activation and cellular protection.
In summary, IGF-I mediates changes in neuronal morphology and activation of FAK via P1 3-K signaling. In contrast, MAP kinase signaling is not required for either of these IGF-I-mediated effects. These results suggest the dissociation of IGF-I signaling for FAK and ERK2 tyrosine phosphorylation and in mediating essential changes in neuronal architecture.
